8
Participants
Start Date
May 9, 2023
Primary Completion Date
October 29, 2024
Study Completion Date
December 3, 2024
Dasiglucagon
Dasiglucagon, 0.6 mg/0.6 mL or 0.3 mg/0.3 mL will be administered as an under the skin (subcutaneous, s.c.) injection by a prefilled syringe, into the buttocks.
Children's Healthcare of Atlanta, Atlanta
Cook Childrens Health Care System, Fort Worth
Lead Sponsor
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Zealand Pharma
INDUSTRY